
Sign up to save your podcasts
Or


Dr. Katie Passaretti, Atrium Health Director of Infection Prevention, discusses being among the first people to receive a Covid-19 vaccine. Robert Califf, Former FDA Commissioner, gives the FDA an A+ for its handling of Covid-19 vaccines. Michael Gapen, Barclays Chief U.S. Economist, sees a bumpy road ahead but vaccine progress gives hope. Peter Orszag, Bloomberg Opinion Columnist and Lazard CEO of Financial Advisory, says more economic pain is coming unless the government acts quickly.
See omnystudio.com/listener for privacy information.
By Bloomberg3.9
11081,108 ratings
Dr. Katie Passaretti, Atrium Health Director of Infection Prevention, discusses being among the first people to receive a Covid-19 vaccine. Robert Califf, Former FDA Commissioner, gives the FDA an A+ for its handling of Covid-19 vaccines. Michael Gapen, Barclays Chief U.S. Economist, sees a bumpy road ahead but vaccine progress gives hope. Peter Orszag, Bloomberg Opinion Columnist and Lazard CEO of Financial Advisory, says more economic pain is coming unless the government acts quickly.
See omnystudio.com/listener for privacy information.

982 Listeners

412 Listeners

2,188 Listeners

1,988 Listeners

434 Listeners

970 Listeners

196 Listeners

188 Listeners

71 Listeners

1,314 Listeners

66 Listeners

77 Listeners

30 Listeners

64 Listeners

4 Listeners

58 Listeners

233 Listeners

231 Listeners

63 Listeners

85 Listeners

85 Listeners

78 Listeners

84 Listeners

402 Listeners

21 Listeners

12 Listeners

8 Listeners

2 Listeners

118 Listeners

24 Listeners